Atrial cardiomyopathy (ACM) is a key independent predictor of stroke. The LeAAPS Trial integrates ACM factors to identify high-risk cardiac surgery patients who may benefit from preventative left atrial appendage exclusion.
Learn more about the trial: <a href="https://t.co/W9PV0ZGzG3" target="_blank">https://t.co/W9PV0ZGzG3</a>… <a href="https://t.co/P83vgNNwW6" target="_blank">https://t.co/P83vgNNwW6</a>